ZLAB
Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited – Zai Lab Limited
Monday, June 27, 2022 BiopharmaWatch Research 1 min read Key Takeaway: Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited – Zai Lab Limited
Price reaction · baseline $34.22 (2022-06-24 close) · clean, no other ZLAB news in the window
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.2%
average across 15 past catalysts
Cash runway
~28 mo
Low dilution risk
Lead asset
ZL-1310
Phase 3 · Small-cell Lung Cancer
Full Press Release Details
Zai Lab Announces Primary Listing on the Main Board of The Stock Exchange of Hong Kong Limited – Zai Lab Limited.